Skip to content

Clinical trials

Phase 4 Lupus Erythematosus, Systemic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 4 Country / region: China Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20151
20161
20201
20213
20222
20232
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status5
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese SLE Treatment And Research Group3
Peking Union Medical College Hospital3
RenJi Hospital2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Tuen Mun Hospital2
Chinese University of Hong Kong1
Fen Li1
GlaxoSmithKline1
Tongji Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic16
Lupus Nephritis2
Autoimmune Diseases1
Lung Diseases, Interstitial1
Pulmonary Arterial Hypertension1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.